Skip To Main Content
Elisabeth C on Muck Rack

Elisabeth C

As seen in: Color Research & Application, Oxford Academic, The International Journal for Quality in Health Care, Frontiers, International Journal of Forecasting

Get in touch with Elisabeth

Contact Elisabeth, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

EndoCompass project : research roadmap for diabetes, obesity, and metabolism

|
By El Ghoch, María Salomón, Elisabeth C
| opendata.uni-halle.de
Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/121558 Title: EndoCompass project : research roadmap for diabetes, obesity, and metabolism Type: Article Language: English URI: https://opendata.uni-halle.de//handle/1981185920/123510 Open Access: Open access publication License: (CC BY 4.0) Creative Commons Attribution 4.0 Journal Title: European journal of endocrinology Publisher: Oxford University Press Publisher Place: Oxford Volume: 193 Issue:...
Open in Who Shared View Duplicates (9) Issue with article?

18F-fluoride PET/CT as an early predictor of bony fusion after posterior lumbar interbody fusion– a prospective study - Journal of Orthopaedic Surgery and Research

|
By Elisabeth C, Ter Laak, Marloes J. M, Wouter A. M
| link.springer.com
Abstract Posterior Lumbar Interbody Fusion (PLIF) is a surgical procedure in which stabilization of spinal segments is achieved by inserting interbody cages filled with bone graft. Positron Emission Tomography (PET) is an imaging modality to assess physiological processes at cellular level, well before manifestation of morphological changes on computed tomography (CT).
Open in Who Shared Issue with article?

Anti-obesity pharmacotherapy for patients with genetic obesity due to defects in the leptin-melanocortin pathway

|
By Van Rossum, Elisabeth C, van den Akker
| Oxford Academic Verified
Lifestyle interventions are the cornerstone of obesity treatment. However, insufficient long-term effects are observed in patients with genetic obesity disorders, as their hyperphagia remains untreated. Hence, patients with genetic obesity often require additional pharmacotherapy to effectively manage and treat their hyperphagia and obesity. Recent advancements in anti-obesity pharmacotherapy have expanded the range of available anti-obesity medications (AOM).
Open in Who Shared Issue with article?
See all 7 articles